DGX QUEST DIAGNOSTICS INC
Research report · from SEC EDGAR · close 2026-07-13
$207.35 -0.0%
$22.95B mkt cap
executive summary
QUEST DIAGNOSTICS INC (DGX) is a $22.95B company. Revenue is $11.04B (+11.8% y/y) at a 9% net margin. It is profitable. Our health score is B (82/100). No major red flags on file. Held by 1 tracked funds. It funds itself; low dilution risk.
Revenue (FY)
$11.04B
+11.8% y/y
✓ No major red flags from our filing-based checks.
who's buying
Insider buys / sells
0 / 3
Cash & ST investments
$393.0M
Operating cash flow
$1.89B
Dilution shelf
active shelf
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices — every figure is real and sourced; nothing is fabricated or predicted. Filings lag 40–90 days. Educational, not investment advice. Generated 2026-07-13 by stocktools.ai.